A new analysis finds that only 37% of the 14 largest public and philanthropic or...
A common blood stem cell complication known as CHIP can turn cancerous. A new st...
Merck plans to acquire Prometheus Biosciences, adding a pipeline of experimental...
What does it mean when a clinical trial is delayed? More than one may think, sai...
Uber says patients who participated in a pilot were slightly more likely to get ...
The new over-the-counter status for naloxone is a no-brainer. But as people who ...
The US Food and Drug Administration has come under criticism recently for delays...
The global market for cancer drugs is growing rapidly, but are we any closer to ...
The pharmaceuticals industry is investing twice as much in R&D as it was a decad...
The US government is imposing transparency rules on the relationship between phy...
Has Andrew Witty got what it takes to keep GlaxoSmithKline at the top? Nicola Bo...
Counterfeiting and fraud are significantly large risk factors when it comes to t...
Japan's acquisitions market has seen surprising growth in recent times, as gener...
The pharmaceutical industry's annual CPhI exhibition is approaching, showcasing ...
Catherine Lafferty looks at the rising influence of biotech on the renewed focus...
